IDEAYA Biosciences (IDYA)
36.23
+1.23 (3.51%)
Upcoming Events
Latest Headlines
IDEAYA Biosciences Announces ESMO 2026 Presentations for Darovasertib and IDE849 Clinical Programs
July 17, 2026 9:00 AM - PR NewsWire
Form 4 IDEAYA Biosciences, Inc. For: Jul 07 Filed by: Ruiz Briseno Andres
July 9, 2026 4:57 PM - SEC Filing
Form 144 IDEAYA Biosciences, Inc. Filed by: Ruiz Briseno Andres
July 7, 2026 4:55 PM - SEC Filing
Ideaya Biosciences (IDYA) PT Lowered to $48 at RBC Capital
July 7, 2026 8:00 AM - StreetInsider
Ideaya Biosciences (IDYA) PT Lowered to $63 at Truist Securities
July 7, 2026 7:09 AM - StreetInsider
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 26, 2026 6:00 AM - PR NewsWire
Form 8-K IDEAYA Biosciences, Inc. For: Jun 16
June 23, 2026 4:06 PM - SEC Filing
Form 4 IDEAYA Biosciences, Inc. For: Jun 16 Filed by: YARNO WENDY L
June 18, 2026 4:34 PM - SEC Filing
Form 4 IDEAYA Biosciences, Inc. For: Jun 16 Filed by: Stein Jeffrey
June 18, 2026 4:34 PM - SEC Filing
Form 4 IDEAYA Biosciences, Inc. For: Jun 16 Filed by: ROSEN TERRY J
June 18, 2026 4:33 PM - SEC Filing
Form 4 IDEAYA Biosciences, Inc. For: Jun 16 Filed by: Morrison Scott W
June 18, 2026 4:33 PM - SEC Filing
Form 4 IDEAYA Biosciences, Inc. For: Jun 16 Filed by: MACKEY CATHERINE J
June 18, 2026 4:32 PM - SEC Filing
Form 4 IDEAYA Biosciences, Inc. For: Jun 16 Filed by: Hampton Malcolm Garret
June 18, 2026 4:31 PM - SEC Filing
IDEAYA Biosciences names CEO Yujiro Hata as board chairman
June 17, 2026 6:01 AM - StreetInsider
IDEAYA Biosciences Announces Yujiro S. Hata Elected Chairman of its Board of Directors
June 17, 2026 6:00 AM - PR NewsWire
IDEAYA starts phase 1/2 trial of IDE892 for pancreatic, lung cancers
June 15, 2026 6:00 AM - StreetInsider
IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates a Phase 1/2 Clinical Combination Study in MTAP-Deleted Pancreatic and Lung Cancers
June 15, 2026 6:00 AM - PR NewsWire
Form 8-K IDEAYA Biosciences, Inc. For: Jun 08
June 10, 2026 4:10 PM - SEC Filing
IDEAYA Biosciences closes $345 million public offering
June 10, 2026 4:05 PM - StreetInsider
IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
June 10, 2026 4:05 PM - PR NewsWire
Form 424B5 IDEAYA Biosciences, Inc.
June 9, 2026 5:17 PM - SEC Filing
Ideaya Biosciences (IDYA) Reiterated at Market Outperform by Citizens
June 9, 2026 4:57 AM - StreetInsider
IDEAYA prices $300 million stock and warrant offering
June 8, 2026 10:23 PM - StreetInsider
IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants
June 8, 2026 10:23 PM - PR NewsWire
Form 424B5 IDEAYA Biosciences, Inc.
June 8, 2026 4:14 PM - SEC Filing
IDEAYA proposes $300 million public offering of common stock and warrants
June 8, 2026 4:01 PM - StreetInsider
IDEAYA Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
June 8, 2026 4:01 PM - PR NewsWire
Form 3 IDEAYA Biosciences, Inc. For: Mar 18 Filed by: Ross Theodora
June 5, 2026 2:06 PM - SEC Filing
Ideaya Biosciences (IDYA) Reiterated at Overweight by Cantor Fitzgerald
June 3, 2026 6:48 AM - StreetInsider
Form 8-K IDEAYA Biosciences, Inc. For: Jun 03
June 3, 2026 6:05 AM - SEC Filing
IDEAYA Biosciences partners with Roche for pancreatic cancer study
June 3, 2026 6:00 AM - StreetInsider
IDEAYA Biosciences Announces Clinical Collaboration with Roche in MTAP-Deleted RAS-Mutant Pancreatic Cancer
June 3, 2026 6:00 AM - PR NewsWire
Ideaya Biosciences (IDYA) Reiterated at Market Outperform by Citizens
June 2, 2026 4:30 AM - StreetInsider
Form 8-K IDEAYA Biosciences, Inc. For: Jun 01
June 1, 2026 4:07 PM - SEC Filing
IDEAYA reports positive phase 2/3 trial results for uveal melanoma drug
June 1, 2026 11:00 AM - StreetInsider
IDEAYA Biosciences and Servier Provide Complete Data from Phase 2/3 Registrational OptimUM-02 Trial of the Darovasertib Combination in First Line HLA*A2:01 Negative Metastatic Uveal Melanoma in a Late
June 1, 2026 11:00 AM - PR NewsWire
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 29, 2026 6:00 AM - PR NewsWire
IDEAYA Biosciences Announces Participation at the 2026 Jefferies Global Healthcare Conference
May 26, 2026 6:00 AM - PR NewsWire
Ideaya Biosciences (IDYA) Reiterated at Overweight by Cantor Fitzgerald
May 22, 2026 7:30 AM - StreetInsider
Form SCHEDULE 13G/A IDEAYA Biosciences, Inc. Filed by: JANUS HENDERSON GROUP PLC
May 15, 2026 12:38 PM - SEC Filing
A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology
May 14, 2026 9:15 AM - StreetInsider
Ideaya Biosciences (IDYA) PT Lowered to $50 at Mizuho
May 7, 2026 6:50 AM - StreetInsider
Form 8-K IDEAYA Biosciences, Inc. For: May 05
May 5, 2026 5:22 PM - SEC Filing
Form 424B5 IDEAYA Biosciences, Inc.
May 5, 2026 5:20 PM - SEC Filing
IDEAYA Biosciences (IDYA) files mixed shelf
May 5, 2026 4:29 PM - StreetInsider
Form S-3ASR IDEAYA Biosciences, Inc.
May 5, 2026 4:28 PM - SEC Filing
Form 10-Q IDEAYA Biosciences, Inc. For: Mar 31
May 5, 2026 4:06 PM - SEC Filing
IDEAYA Biosciences (IDYA) Misses Q1 EPS by 12c
May 5, 2026 6:19 AM - StreetInsider
Form 8-K IDEAYA Biosciences, Inc. For: May 05
May 5, 2026 6:08 AM - SEC Filing
IDEAYA Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update
May 5, 2026 6:00 AM - PR NewsWire
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026 6:00 AM - PR NewsWire
Form DEFA14A IDEAYA Biosciences, Inc.
April 30, 2026 4:09 PM - SEC Filing
IDEAYA begins FDA application for uveal melanoma drug under fast-track program
April 30, 2026 6:01 AM - StreetInsider
IDEAYA Biosciences to Initiate New Drug Application Submission from the Darovasertib OptimUM-02 Trial under the Oncology Center of Excellence Real-time Oncology Review (RTOR) Program
April 30, 2026 6:00 AM - PR NewsWire
Form DEF 14A IDEAYA Biosciences, Inc. For: Jun 16
April 29, 2026 4:07 PM - SEC Filing
Form ARS IDEAYA Biosciences, Inc. For: Dec 31
April 29, 2026 4:05 PM - SEC Filing
Full Article List
